Email this article 
Results of the study of Cinocap cream clinical efficacy andsafety
- Authors: Danilova AA1, Kosorukova IM1, Danilova AA1, Kosorukova IM1
-
Affiliations:
- Issue: Vol 86, No 6 (2010)
- Pages: 107-114
- Section: Articles
- Submitted: 11.03.2020
- Published: 15.12.2010
- URL: https://vestnikdv.ru/jour/article/view/848
- DOI: https://doi.org/10.25208/vdv848
- ID: 848
Cite item
Full Text
Abstract
There was a study of the efficacy and safety of a zinc pyrithione drug, Cinocap® cream, in 40 psoriasis patients. The therapeutic
equivalence of the drug to the original drug, Skin-Cap® cream, was also assessed. Patients aged 18-65 were randomized into
two groups: patients from the first group received a treatment with Cinocap® cream while patients from the second group were
treated with Skin-Cap® cream for 45 days. It was proved that Cinocap® cream is an efficient drug for the treatment of psoriasis and
is comparable to the original drug, Skin-Cap® cream, by its therapeutic effect and safety.
equivalence of the drug to the original drug, Skin-Cap® cream, was also assessed. Patients aged 18-65 were randomized into
two groups: patients from the first group received a treatment with Cinocap® cream while patients from the second group were
treated with Skin-Cap® cream for 45 days. It was proved that Cinocap® cream is an efficient drug for the treatment of psoriasis and
is comparable to the original drug, Skin-Cap® cream, by its therapeutic effect and safety.
Keywords
About the authors
A A Danilova
Email: info@cnikvi.ru
I M Kosorukova
Email: info@cnikvi.ru
A A Danilova
I M Kosorukova
References
- Вульф К., Джонсон Р., Сюрмонд Д. Дерматология. М.: Практи ка, 2007; 98-126.
- Скрипкин Ю.К. , Мордовцев В.Н. Кожные и венерические болезни. М.: Медицина, 1999; 2: 880.
- Каламкарян А.А. и др. Редкие атипичные дерматозы. ВИН: Клиническая дерматология. Ереван: Айстан, 1989; 174-175.
- Адаскевич В.П., Козин В.М. Кожные и венерические болезни. М.: Медицинская литература, 2006: 672.
- Чистякова И.А. Соснина Е.А. Особенности клинических проявлений в терапии больных пустулезным псориазом. Concilium Medicum. 2009; 2: 11-17.
- Джеймс Е. Фицпатрик, Джонс. Л. Элинг. Секреты дерматологии. М.: ЗАО Издательство Бином, 1999; 57-61.
- Ricotti G, Kerdel FA. Treatment of pustular psoriasis: JEADV 2007; 5: 23-57.
- Томас П. Хэбиф. Кожные болезни. Диагностика и лечение. М.: МЕД пресс-информ, 2008; 114-120: 632.
- Скрипкин Ю.К., Петровский Ф.И., Феденко Е.С., Пампура А.Н., Коростовцев, Д.С. Фассахов Р.С., Сукманская Е.О. Рос. аллергол. журн., 2007; 3: 34-35.
- Guthery E., Seal L.A., Anderson E.L. Zinc pyrithione in alcohol:based products for skin antisepsis: persistence of antimicrobial effects. Am. J. Infect. Control., 2005; 33 (1): 15-22.
- Rogers J.S., Moore A.E., Meldrum H., Harding C.R. Increased scalp skin lipids in response to antidandruff treatment containing zinc pyrithione. Arch. Dermatol. Res., 2003; 295: 127-129.
- Казначеев К.С., Казначеева Л.Ф., Молокова А.В. Аллергология, 2006; 3: 15-16.
- Казначеев К.С. и др. Рос. аллергол. журн., 2004; 2: 18-19.
Supplementary files
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).